Minimum Residual Disease in Acute Lymphoblastic Leukemia

5 Views
administrator
administrator
08/04/23

In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next